Sims, J. E. et al. A new nomenclature for IL-1-family genes. Trends Immunol. 22, 536–537 (2001).
Dinarello, C. et al. IL-1 family nomenclature. Nat. Immunol. 11, 973 (2010).
van de Veerdonk, F. L. & Netea, M. G. New insights in the immunobiology of IL-1 family members. Front. Immunol. 4, 167 (2013).
Towne, J. E. et al. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappa B and MAPKs. J. Biol. Chem. 279, 13677–13688 (2004).
Debets, R. et al. Two novel IL-1 family members, IL-1delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J. Immunol. 167, 1440–1446 (2001).
Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 365, 620–628 (2011).
Onoufriadis, A. et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am. J. Hum. Genet. 89, 432–437 (2011).
Sugiura, K. et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J. Invest. Dermatol. 133, 2514–2521 (2013).
Akiyama, M. et al. Autoinflammatory keratinization diseases. J. Allergy Clin. Immunol. 140, 1545–1547 (2017).
Akiyama, M. et al. Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin. J. Dermatol. Sci. 90, 105–111 (2018).
Shibata, A. et al. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA. J. Autoimmun. 80, 28–38 (2017).
Blumberg, H. et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J. Exp. Med. 204, 2603–2614 (2007).
Fukushima, H. et al. TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency. Sci. Rep. 10, 734 (2020).
Sugiura, K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J. Dermatol. Sci. 74, 187–192 (2014).
Moniaga, C. S., Watanabe, S., Honda, T., Nielsen, S. & Hara-Chikuma, M. Aquaporin-9-expressing neutrophils are required for the establishment of contact hypersensitivity. Sci. Rep. 5, 15319 (2015).
Christensen, A. D., Skov, S. & Haase, C. The role of neutrophils and G-CSF in DNFB-induced contact hypersensitivity in mice. Immun. Inflamm. Dis. 2, 21–34 (2014).
Goebeler, M. et al. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am. J. Pathol. 158, 431–440 (2001).
Jiang, Z. et al. IL-36γ Induced by the TLR3-SLUG-VDR Axis Promotes Wound Healing via REG3A. J. Invest. Dermatol. 137, 2620–2629 (2017).
Geoffrey, C. Gurtner. Wound repair and regeneration. Nature 453, 314–321 (2018).
Ishida, Y. et al. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappa B activation and a reciprocal suppression of TGF-beta signal pathway. J. Immunol. 176, 5598–5606 (2006).
Suga, H. et al. TLR4, rather than TLR2, regulates wound healing through TGF-β and CCL5 expression. J. Dermatol. Sci. 73, 117–124 (2014).
Oshio, T. et al. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice. J. Dermatol. Sci. 85, 106–114 (2017).
Chen, L. et al. Toll-like receptor 4 has an essential role in early skin wound healing. J. Invest. Dermatol. 133, 258–267 (2013).
Taylor, K. R. et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079–17084 (2004).
Foell, D., Wittkowski, H., Vogl, T. & Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28–37 (2007).
Sims, G. P. et al. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28, 367–388 (2010).
Jiang, D. et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173–1179 (2005).
Muto, J., Sayama, K., Gallo, R. L. & Kimata, K. Emerging evidence for the essential role of hyaluronan in cutaneous biology. J. Dermatol. Sci. 94, 190–195 (2019).
Ding, L. et al. IL-36 cytokines in autoimmunity and inflammatory disease. Oncotarget 9, 2895–2901 (2017).
Ritchlin, C. et al. Patterns of cytokine production in psoriatic synovium. J. Rheumatol. 25, 1544–1552 (1998).
Chustz, R. T. et al. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 45, 145–153 (2011).
Berglöf, E. et al. IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells. J. Neuroimmunol. 139, 36–43 (2003).
Lin, Q. et al. Impaired wound healing with defective expression of chemokines and recruitment of myeloid cell in TLR3-deficient mice. J. Immunol. 186, 3710–3717 (2011).
Iwata, Y. et al. CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. Am. J. Pathol. 175, 649–660 (2009).
Clancy, D. M. et al. Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines. FEBS J. 284, 1712–1725 (2017).
Afonina, I. S. et al. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. Mol. Cell. 44, 265–278 (2011).
Lefrancais, E. et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 109, 1673–1678 (2012).
Afonina, I. S., Müller, C., Martin, S. J. & Beyaert, R. Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42, 991–1004 (2015).
Foster, A. M. et al. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J. Immunol. 192, 6053–6061 (2014).
Gabay, C. & Towne, J. E. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions. J. Leukoc. Biol. 97, 645–652 (2015).
Arend, W. P., Malyak, M., Guthridge, C. J. & Gabay, C. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16, 27–55 (1998).
Johnson, G. B., Brunn, G. J. & Platt, J. L. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J. Immunol. 172, 20–24 (2004).
Taylor, K. R. et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282, 18265–18275 (2007).
Aruffo, A. et al. CD44 Is the principal cell surface receptor for hyaluronate. Cell 61, 1303–1313 (1990).
Jiang, D. et al. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23, 435–461 (2007).
Neuman, M. G., Nanau, R. M., Oruña-Sanchez, L. & Coto, G. Hyaluronic acid and wound healing. J. Pharm. Pharm. Sci. 18, 53–60 (2015).
Chen, L. & DiPietro, L. A. Toll-like receptor function in acute wounds. Adv. Wound Care 16, 344–355 (2017).
Benomar, Y. et al. Central resistin overexposure induces insulin resistance through Toll-like receptor 4. Diabetes 62, 102–114 (2013).
Julian, M. W. et al. Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis. Chest 143, 461–470 (2013).
Postlethwaite, A. E., Keski-Oja, J., Moses, H. L. & Kang, A. H. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J. Exp. Med. 165, 251–256 (1987).
Miyazono, K., Hellman, U., Wernstedt, C. & Heldin, C. H. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J. Biol. Chem. 263, 6407–6415 (1988).
Pircher, R., Jullien, P. & Lawrence, D. A. Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. Biophys. Res. Commun. 136, 30–37 (1986).
Babaioo, A. R. et al. Evaluation of the effect of IL-36γ expression on chronic periodontitis by enhancing the MAPK and TLR4 signaling pathways: a basic research. J. Dent. Res. Dent. Clin. Dent. Prosp. 12, 159–165 (2018).
Lai, Y. et al. Commensal bacteria regulate toll-like receptor 3-dependent infammation after skin injury. Nat. Med. 15, 1377–1382 (2009).
Wong, V. W. et al. Surgical approaches to create murine models of human wound healing. J. Biomed. Biotechnol. https://doi.org/10.1155/2011/969618 (2011).
Sasaki, H., Akamatsu, H. & Horio, T. Protective role of copper, zinc superoxide dismutase against UVB-induced injury of the human keratinocyte cell line HaCaT. J. Invest. Dermatol. 114, 502–507 (2000).
Boukamp, P. et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761–771 (1988).